Lv52
1470 积分 2022-08-08 加入
Validation of the Swedish Diabetes Re-Grouping Scheme in Adult-Onset Diabetes in China
6天前
已关闭
Tirzepatide, a dual glucose‐dependent insulinotropic polypeptide/glucagon‐like peptide 1 receptor agonist, exhibits favourable effects on pancreatic β‐cells and hepatic steatosis in obese type 2 diabetic db/db mice
11天前
已完结
Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trial
13天前
已完结
Intensive lifestyle intervention, cardiac biomarkers, and cardiovascular outcomes in diabetes: LookAHEAD cardiac biomarker ancillary study
17天前
已完结
Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes
21天前
已完结
Potential Benefits of Weight Loss in Coronary Heart Disease
24天前
已完结
Features, functions, and associated diseases of visceral and ectopic fat: a comprehensive review
24天前
已完结
Comparing clinical outcomes of adults with obesity receiving tirzepatide versus bariatric metabolic surgery: A multi‐institutional propensity score‐matched study
26天前
已完结
Changes in Gut Microbiota and Hormones After Bariatric Surgery: a Bench-to-Bedside Review
27天前
已完结
Does BMI Matter? A 10-Year Single Institutional Experience on 571 Bariatric Surgery Patients With BMI >50 kg/m2
27天前
已完结
皖公网安备34019202002308
